Today my cousin Christopher would have turned 35, except Christopher died 3 days ago.
There is an indescribable feeling of failure, being so entrenched in the mental health field but being unable to help those you love. I'm not sure why I'm sharing, except maybe to put a face
Due Today! ACNP is accepting Early-Stage Investigator Assistance Program & Associate Member Assistance Program applications for the ACNP 65th Annual Meeting, Jan. 10-13, 2027, San Diego, CA. Deadline: Oct. 30, 2026, at 5 pm CST. For more info, visit: https://t.co/O7vpCa7e1a
Check out our new Deep Dive on the recent ACNP @ACNPorg position paper that lays out actionable strategies to advance biomarker-enabled precision psychiatry and improve coordination across scientific, regulatory, clinical, and commercial stakeholders.
https://t.co/9Ffxfob8tF
A belated thank you to @EurBehavPharm for the EBPS travel award, which helped fund my trip to Amsterdam where I presented my first data blitz! So grateful to my supervisor, @MayoOnTheBrain, for sending me and for the opportunity to share my research & make some great connections
Apply for our New Investigator Award for an opportunity to have your manuscript in preparation be considered for publication in DPN and have your publishing fees waived!
Apply by Nov 13👇
Symposia Submissions for #EBPS2027 in Cork, Ireland are now open. We have a great lineup of keynote presentations and are seeking symposia proposals covering a range of behavioural pharmacology topics.
More information on our website
https://t.co/Gm9Cxjwx5o
**Recruitment**
We are looking to hire a psychiatrist/scientist (MD or MD/PhD) who focuses on neuromodulation, particularly rTMS in the Department of Psychiatry at the University of Calgary. Come join myself, @MayoOnTheBrain and more.
Details 👇
https://t.co/IbI1AQBOFm
New lab paper led by @farhana_yasmn
describing potential new mechanisms underlying context-dependent adverse anxiety effects of cannabinoids...
https://t.co/jgXrUS8WiR
**Recruitment**
We are looking to hire a psychiatrist/scientist (MD or MD/PhD) who focuses on neuromodulation, particularly rTMS in the Department of Psychiatry at the University of Calgary. Come join myself, @MayoOnTheBrain and more.
Details 👇
https://t.co/IbI1AQBOFm
Brain Canada is thrilled to announce the new cohort of Future Leaders in Canadian Brain Research. This year, 26 brilliant researchers join this growing community, and each receive $100,000. 🎉 Congratulations to the recipients! Find out more about this year’s Future Leaders: https://t.co/0lihAAE4Us @azrielifdn@HeartandStroke@CIHR_IA
See our new publication on exploratory safety, tolerability, and feasibility of psilocybin-assisted psychotherapy for adults with co-occurring treatment-resistant depression and cluster B personality disorders
@UofTNews@CPIN_UofT@UofTPsych
https://t.co/2Kyz62Rybr
See our RCT published today @JAMAPsych
Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression (TRBD)
In TRBD, adjunctive IV ketamine was well tolerated and associated with significant antidepressant effects.
@UofTPsych@KBI_UHN@UHN
https://t.co/bZLqN3VNHJ
@kamelnyk They were just talking about our next ACNP trip to the Bahamas and nominated you as their water slide buddy, so I hope you are prepared to live up to their expectations 😂
Deadline fast approaching! Poster Submissions for the ACNP 65th Annual Meeting are due by August 27, 2026! January 10-13, 2027, San Diego, California. You must be registered for the meeting before you can submit a poster. #ACNP2027 https://t.co/c6LCtjYE76
Important new paper just dropped in @NatureMedicine.
Multi-site, randomized, double blind, placebo controlled trial demonstrates that THC significantly reduces nightmare frequency and intensity in PTSD.
This is a big step forward for medical cannabis.
https://t.co/7Zp7Xbypeg
It's a new month and a new roundup of what's new #ThisWeekinNPP
See below for the latest insights on the impact of synthetic coolants in nicotine-containing e-cigarettes and how cortisol suppression impacts emotional memory in humans 👇 #TWiNPP